• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三联征:甲状腺细胞病理学、分子检测与组织病理学的相关性。

A Triumvirate:: Correlating Thyroid Cytopathology, Molecular Testing, and Histopathology.

机构信息

Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, 1400 NW 12(th) Avenue, Miami, FL 33136, USA. Electronic address: https://twitter.com/JaylouVelez.

Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, 1400 NW 12(th) Avenue, Miami, FL 33136, USA. Electronic address: https://twitter.com/Y_Tjendra.

出版信息

Surg Pathol Clin. 2023 Mar;16(1):1-14. doi: 10.1016/j.path.2022.09.003. Epub 2022 Dec 8.

DOI:10.1016/j.path.2022.09.003
PMID:36739157
Abstract

Risk stratification is essential in the preoperative evaluation and management of thyroid nodules, most of which are benign. Advances in DNA and RNA sequencing have shed light on the molecular drivers of thyroid cancer. Molecular testing of cytologically indeterminate nodules has helped refine risk stratification, triage patients for surgery, and determine the extent of surgery. Molecular platforms with high negative predictive values can help identify nodules that may be spared surgery and can be managed conservatively. Here we discuss the importance of integrating cytomorphologic, molecular, and histologic features to help avoid errors and improve patient management.

摘要

风险分层在甲状腺结节的术前评估和管理中至关重要,大多数甲状腺结节都是良性的。DNA 和 RNA 测序的进展揭示了甲状腺癌的分子驱动因素。对细胞学不确定的结节进行分子检测有助于完善风险分层,为手术患者进行分诊,并确定手术范围。具有高阴性预测值的分子平台有助于识别可能免于手术且可以保守治疗的结节。在这里,我们讨论了整合细胞形态学、分子和组织学特征的重要性,以帮助避免错误并改善患者管理。

相似文献

1
A Triumvirate:: Correlating Thyroid Cytopathology, Molecular Testing, and Histopathology.三联征:甲状腺细胞病理学、分子检测与组织病理学的相关性。
Surg Pathol Clin. 2023 Mar;16(1):1-14. doi: 10.1016/j.path.2022.09.003. Epub 2022 Dec 8.
2
Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.临床实践中使用ThyroSeq v2.1对甲状腺结节进行二代测序靶向检测
Del Med J. 2016 Dec;88(12):366-372.
3
PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.甲状腺结节细胞学检查中体突变对恶性肿瘤发展的预测价值。
Endocr Pract. 2016 Sep;22(9):1081-7. doi: 10.4158/EP151057.OR. Epub 2016 May 23.
4
Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance.重复细针穿刺细胞学检查显示非诊断性或良性的甲状腺结节细胞学分型不确定患者的风险分层:对分子检测和监测的影响。
Cancer Cytopathol. 2023 May;131(5):313-324. doi: 10.1002/cncy.22684. Epub 2023 Feb 15.
5
Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.分子检测技术在诊断甲状腺结节中的有效性:一项随机临床试验。
JAMA Oncol. 2021 Jan 1;7(1):70-77. doi: 10.1001/jamaoncol.2020.5935.
6
Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with postoperative molecular testing.使用Afirma Xpression图谱对细胞学检查结果不确定、Afirma基因组测序分类器检测为可疑的甲状腺结节进行分析:术后分子检测的临床病理分析
Am J Clin Pathol. 2024 May 2;161(5):463-468. doi: 10.1093/ajcp/aqad169.
7
An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.一项关于基因表达分类器(Afirma)在评估细胞学不确定的甲状腺结节中的独立研究。
J Clin Endocrinol Metab. 2014 Nov;99(11):4069-77. doi: 10.1210/jc.2013-3584. Epub 2014 Apr 29.
8
American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.美国放射学院甲状腺影像报告和数据系统联合 K-RAS 突变可改善细胞学不确定的甲状腺结节的管理。
PLoS One. 2019 Jul 11;14(7):e0219383. doi: 10.1371/journal.pone.0219383. eCollection 2019.
9
A retrospective analysis of molecular testing in cytologically indeterminate thyroid nodules with histologic correlation: Experience at a heterogenous multihospital system.回顾性分析伴有组织学相关性的细胞学不确定甲状腺结节的分子检测:多医院异质系统的经验。
Diagn Cytopathol. 2024 Feb;52(2):82-92. doi: 10.1002/dc.25250. Epub 2023 Nov 10.
10
Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.采用联合分子分类器对细针抽吸细胞学(FNAC)涂片的不明确细胞学(Bethesda III、IV)进行术前恶性肿瘤检测。
J Clin Pathol. 2020 Nov;73(11):722-727. doi: 10.1136/jclinpath-2020-206445. Epub 2020 Mar 25.

引用本文的文献

1
Mutational Profiling Detection in FNAC Samples of Different Types of Thyroid Neoplasms Using Targeted NGS.使用靶向二代测序技术检测不同类型甲状腺肿瘤细针穿刺活检样本中的突变谱
Cancers (Basel). 2025 Jul 23;17(15):2429. doi: 10.3390/cancers17152429.
2
Precision Medicine in Cytopathology.细胞病理学中的精准医学。
Surg Pathol Clin. 2024 Sep;17(3):329-345. doi: 10.1016/j.path.2024.04.002. Epub 2024 May 18.